Stay updated on ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Sign up to get notified when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.

Latest updates to the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 on the study page, representing an administrative update with no changes to study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedUI updates include the glossary toggle and capitalization changes to QC-related labels. The revision tag has been updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page header, a minor maintenance change with no impact on content or functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with France as a study site and updated the page revision to v3.3.3; the old France Locations entry was removed.SummaryDifference0.2%

- Check70 days agoChange DetectedAdded a Publications entry with a 2022 safety and pharmacokinetics citation and a Study Results section. Updated the France Locations to reflect current sites and removed some earlier listings, with the last update dated 2025-12-05.SummaryDifference1%

Stay in the know with updates to ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ROSCO-CF Safety in F508del-CFTR Homozygous Clinical Trial page.